11/09/2026 | Press release | Archived content
Evaluations
This final management advisory informs the DoW of health and safety risks resulting from the Department's lack of: (1) oversight of the clinical quality management for health care provided by Department of the Navy personnel assigned to the Office of the Attending Physician (OAP) and (2) verification that the OAP pharmacy has undergone required inspections and inventories. Due to the unique nature of the OAP, we only focused our review on the DoW's ability to oversee the clinical quality management and pharmacy operations conducted by the Navy, for which we have oversight responsibility.